Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Macdonell

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
EJNMMI Research|April 27, 2013
In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106Akihiro Takano, Fredrik Piehl, Jan Hillert, et al.
Therapeutic Advances in Neurological Disorders|May 5, 2021
High rates of JCV seroconversion in a large international cohort of natalizumab-treated patientsChristopher M Dwyer, Vilija G Jokubaitis, Jim Stankovich, et al.
Journal of the Neurological Sciences|November 8, 2017
The professional practice and training of neurology in the Asian and Oceanian Region: A cross-sectional survey by the Asian and Oceanian Association of Neurology (AOAN)Artemio Roxas, Man Mohan Mehndiratta, Natan Bornstein, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 27, 2024
Effectiveness of autologous haematopoietic stem cell transplantation versus natalizumab in progressive multiple sclerosisTomas Kalincik, Sifat Sharmin, Izanne Roos, et al.
European Journal of Neurology|April 23, 2022
Psychometric deficits in autoimmune encephalitis: A retrospective study from the Australian Autoimmune Encephalitis ConsortiumSarah Griffith, Robb Wesselingh, James Broadley, et al.
Brain Communications|March 18, 2024
Dominant <i>NARS1</i> mutations causing axonal Charcot-Marie-Tooth disease expand <i>NARS1</i>-associated diseasesDanique Beijer, Sheila Marte, Jiaxin C Li, et al.
JAMA Neurology|September 29, 2025
Menopause Impact on Multiple Sclerosis Disability ProgressionFrancesca Bridge, Paul G Sanfilippo, Chao Zhu, et al.
Multiple Sclerosis and Related Disorders|March 15, 2026
Characterising executive functioning in the chronic phase of autoimmune encephalitis: A study by the Australian autoimmune encephalitis consortiumKatherine Y Ko, Nabil Seery, Sarah Griffith, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 26, 2022
Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registryTim Spelman, Serkan Ozakbas, Raed Alroughani, et al.
Brain : a Journal of Neurology|December 12, 2023
Vitamin D did not reduce multiple sclerosis disease activity after a clinically isolated syndromeHelmut Butzkueven, Anne-Louise Ponsonby, Mark S Stein, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
EJNMMI Research|April 27, 2013
In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106Akihiro Takano, Fredrik Piehl, Jan Hillert, et al.
Therapeutic Advances in Neurological Disorders|May 5, 2021
High rates of JCV seroconversion in a large international cohort of natalizumab-treated patientsChristopher M Dwyer, Vilija G Jokubaitis, Jim Stankovich, et al.
Journal of the Neurological Sciences|November 8, 2017
The professional practice and training of neurology in the Asian and Oceanian Region: A cross-sectional survey by the Asian and Oceanian Association of Neurology (AOAN)Artemio Roxas, Man Mohan Mehndiratta, Natan Bornstein, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 27, 2024
Effectiveness of autologous haematopoietic stem cell transplantation versus natalizumab in progressive multiple sclerosisTomas Kalincik, Sifat Sharmin, Izanne Roos, et al.
European Journal of Neurology|April 23, 2022
Psychometric deficits in autoimmune encephalitis: A retrospective study from the Australian Autoimmune Encephalitis ConsortiumSarah Griffith, Robb Wesselingh, James Broadley, et al.
Brain Communications|March 18, 2024
Dominant <i>NARS1</i> mutations causing axonal Charcot-Marie-Tooth disease expand <i>NARS1</i>-associated diseasesDanique Beijer, Sheila Marte, Jiaxin C Li, et al.
JAMA Neurology|September 29, 2025
Menopause Impact on Multiple Sclerosis Disability ProgressionFrancesca Bridge, Paul G Sanfilippo, Chao Zhu, et al.
Multiple Sclerosis and Related Disorders|March 15, 2026
Characterising executive functioning in the chronic phase of autoimmune encephalitis: A study by the Australian autoimmune encephalitis consortiumKatherine Y Ko, Nabil Seery, Sarah Griffith, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 26, 2022
Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registryTim Spelman, Serkan Ozakbas, Raed Alroughani, et al.
Brain : a Journal of Neurology|December 12, 2023
Vitamin D did not reduce multiple sclerosis disease activity after a clinically isolated syndromeHelmut Butzkueven, Anne-Louise Ponsonby, Mark S Stein, et al.
Pageof 6